IL34 and hepatocellular carcinoma: Thus, this early finding should be further verified in humanized animals with full immunity in the future, particularly inoculating via the portal vein to better mimic real-world conditions, to investigate the role of the hosts local and systemic immunity in the augmentation of HCC, particularly in relationship with IL-34, perhaps using IL-34 manipulated animals.